BR vs MREO · P/E 16, rev $7.48B vs $48.7M cap
Broadridge Financial Solutions Inc (BR) versus Mereo BioPharma Group PLC ADR (MREO) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported BR revenue for 2026-06-30 was $7.48B. Net income was $1.12B. Revenue was up 8.5% from 2025-06-30 to 2026-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
BR currently screens at market cap $17.65B and trailing P/E 16.3. MREO currently screens at market cap $48.7M.
Not investment advice. Open the BR and MREO stock pages for the full models.
Not investment advice.